X-38401393-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_000531.6(OTC):c.505C>T(p.Pro169Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000531.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.505C>T | p.Pro169Ser | missense_variant | Exon 5 of 10 | ENST00000039007.5 | NP_000522.3 | |
OTC | NM_001407092.1 | c.505C>T | p.Pro169Ser | missense_variant | Exon 7 of 12 | NP_001394021.1 | ||
OTC | XM_017029556.2 | c.505C>T | p.Pro169Ser | missense_variant | Exon 5 of 9 | XP_016885045.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:1
This variant has been observed in individual(s) with ornithine transcarbamylase deficiency (Invitae). In at least one individual the variant was observed to be de novo. This sequence change replaces proline with serine at codon 169 of the OTC protein (p.Pro169Ser). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and serine. This variant is not present in population databases (ExAC no frequency). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OTC protein function. This variant disrupts the p.Pro169 amino acid residue in OTC. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11793468, 11117428, 26059767). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.